Detecting breast cancer typically involves a combination of screening tests and diagnostic procedures. Screening tests are used to identify potential signs of cancer in women who have no symptoms, while diagnostic procedures are performed when there are signs or symptoms of breast cancer.
MITOS Medical Technologies has developed SAFE (Scan and Find Early), a groundbreaking microwave imaging device designed for breast cancer screening and early detection. SAFE utilizes harmless electromagnetic waves instead of X-rays, making it a safe and non-invasive alternative for breast cancer detection. Its non-compressive nature provides a more comfortable experience for patients and enables the detection of tumors near the thoracic wall, which can be missed by traditional methods.
In a study involving 115 patients, SAFE demonstrated a sensitivity of 63% in detecting breast abnormalities. The study also found that breast size influenced the sensitivity of SAFE, with larger breasts showing a higher sensitivity of 74% compared to 51% in smaller breasts. These results are promising and suggest that SAFE has the potential to be an effective screening tool for a wide range of breast sizes.
Early detection of breast cancer is associated with better treatment outcomes and higher survival rates. Regular screening and prompt follow-up of any suspicious findings are essential for early detection.
Breast cancer detection relies on a combination of screening tests and diagnostic procedures. Women should be proactive about their breast health, performing regular self-exams, attending clinical breast exams, and following recommended screening guidelines based on their age and risk factors. By understanding the tools and methods used for breast cancer detection, women can take an active role in their health and well-being, potentially leading to earlier detection and improved outcomes in the fight against breast cancer.